| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 4 | 
| Pissara et al. | yes | yes: 20 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | yes | yes: 7 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 | 
| NetGPI | no | yes: 0, no: 11 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005634 | nucleus | 5 | 12 | 
| GO:0032991 | protein-containing complex | 1 | 12 | 
| GO:0043226 | organelle | 2 | 12 | 
| GO:0043227 | membrane-bounded organelle | 3 | 12 | 
| GO:0043229 | intracellular organelle | 3 | 12 | 
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 12 | 
| GO:0110165 | cellular anatomical entity | 1 | 12 | 
| GO:1990904 | ribonucleoprotein complex | 2 | 12 | 
| GO:0005654 | nucleoplasm | 2 | 1 | 
Related structures:
AlphaFold database: A0A3Q8IB28
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 | 
| GO:0006396 | RNA processing | 6 | 12 | 
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 | 
| GO:0006807 | nitrogen compound metabolic process | 2 | 12 | 
| GO:0008152 | metabolic process | 1 | 12 | 
| GO:0009987 | cellular process | 1 | 12 | 
| GO:0016070 | RNA metabolic process | 5 | 12 | 
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 | 
| GO:0043170 | macromolecule metabolic process | 3 | 12 | 
| GO:0044237 | cellular metabolic process | 2 | 12 | 
| GO:0044238 | primary metabolic process | 2 | 12 | 
| GO:0046483 | heterocycle metabolic process | 3 | 12 | 
| GO:0071704 | organic substance metabolic process | 2 | 12 | 
| GO:0090304 | nucleic acid metabolic process | 4 | 12 | 
| GO:1901360 | organic cyclic compound metabolic process | 3 | 12 | 
| GO:0006399 | tRNA metabolic process | 7 | 1 | 
| GO:0008033 | tRNA processing | 8 | 1 | 
| GO:0034470 | ncRNA processing | 7 | 1 | 
| GO:0034660 | ncRNA metabolic process | 6 | 1 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 12 | 
| GO:0003723 | RNA binding | 4 | 12 | 
| GO:0005488 | binding | 1 | 12 | 
| GO:0097159 | organic cyclic compound binding | 2 | 12 | 
| GO:1901363 | heterocyclic compound binding | 2 | 12 | 
| GO:0003729 | mRNA binding | 5 | 1 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 151 | 155 | PF00656 | 0.468 | 
| CLV_NRD_NRD_1 | 125 | 127 | PF00675 | 0.450 | 
| CLV_NRD_NRD_1 | 191 | 193 | PF00675 | 0.663 | 
| CLV_NRD_NRD_1 | 330 | 332 | PF00675 | 0.812 | 
| CLV_NRD_NRD_1 | 80 | 82 | PF00675 | 0.488 | 
| CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.411 | 
| CLV_PCSK_KEX2_1 | 125 | 127 | PF00082 | 0.451 | 
| CLV_PCSK_KEX2_1 | 193 | 195 | PF00082 | 0.706 | 
| CLV_PCSK_KEX2_1 | 330 | 332 | PF00082 | 0.730 | 
| CLV_PCSK_KEX2_1 | 80 | 82 | PF00082 | 0.486 | 
| CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.411 | 
| CLV_PCSK_PC1ET2_1 | 193 | 195 | PF00082 | 0.704 | 
| CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.330 | 
| CLV_PCSK_SKI1_1 | 278 | 282 | PF00082 | 0.621 | 
| CLV_PCSK_SKI1_1 | 82 | 86 | PF00082 | 0.588 | 
| DOC_CKS1_1 | 210 | 215 | PF01111 | 0.728 | 
| DOC_MAPK_gen_1 | 140 | 149 | PF00069 | 0.451 | 
| DOC_MAPK_gen_1 | 7 | 14 | PF00069 | 0.388 | 
| DOC_MAPK_HePTP_8 | 137 | 149 | PF00069 | 0.591 | 
| DOC_MAPK_MEF2A_6 | 140 | 149 | PF00069 | 0.437 | 
| DOC_PP1_RVXF_1 | 8 | 15 | PF00149 | 0.523 | 
| DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.491 | 
| DOC_USP7_MATH_1 | 136 | 140 | PF00917 | 0.610 | 
| DOC_USP7_MATH_1 | 216 | 220 | PF00917 | 0.516 | 
| DOC_USP7_MATH_1 | 63 | 67 | PF00917 | 0.577 | 
| DOC_WW_Pin1_4 | 209 | 214 | PF00397 | 0.637 | 
| LIG_14-3-3_CanoR_1 | 278 | 283 | PF00244 | 0.545 | 
| LIG_14-3-3_CanoR_1 | 49 | 54 | PF00244 | 0.534 | 
| LIG_APCC_ABBA_1 | 259 | 264 | PF00400 | 0.470 | 
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.618 | 
| LIG_BIR_III_2 | 83 | 87 | PF00653 | 0.567 | 
| LIG_FHA_1 | 102 | 108 | PF00498 | 0.459 | 
| LIG_FHA_1 | 174 | 180 | PF00498 | 0.477 | 
| LIG_FHA_1 | 93 | 99 | PF00498 | 0.448 | 
| LIG_FHA_2 | 151 | 157 | PF00498 | 0.438 | 
| LIG_FHA_2 | 252 | 258 | PF00498 | 0.619 | 
| LIG_LIR_Apic_2 | 95 | 100 | PF02991 | 0.444 | 
| LIG_LIR_Gen_1 | 13 | 22 | PF02991 | 0.531 | 
| LIG_LIR_Gen_1 | 144 | 150 | PF02991 | 0.424 | 
| LIG_LIR_Gen_1 | 230 | 240 | PF02991 | 0.492 | 
| LIG_LIR_Gen_1 | 46 | 53 | PF02991 | 0.540 | 
| LIG_LIR_Nem_3 | 13 | 19 | PF02991 | 0.531 | 
| LIG_LIR_Nem_3 | 144 | 149 | PF02991 | 0.417 | 
| LIG_LIR_Nem_3 | 230 | 235 | PF02991 | 0.483 | 
| LIG_LIR_Nem_3 | 36 | 41 | PF02991 | 0.523 | 
| LIG_LIR_Nem_3 | 46 | 50 | PF02991 | 0.523 | 
| LIG_Pex14_1 | 124 | 128 | PF04695 | 0.450 | 
| LIG_SH2_CRK | 165 | 169 | PF00017 | 0.627 | 
| LIG_SH2_PTP2 | 97 | 100 | PF00017 | 0.454 | 
| LIG_SH2_SRC | 178 | 181 | PF00017 | 0.661 | 
| LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.515 | 
| LIG_SH2_STAT5 | 15 | 18 | PF00017 | 0.538 | 
| LIG_SH2_STAT5 | 178 | 181 | PF00017 | 0.487 | 
| LIG_SH2_STAT5 | 249 | 252 | PF00017 | 0.460 | 
| LIG_SH2_STAT5 | 97 | 100 | PF00017 | 0.454 | 
| LIG_SH3_3 | 156 | 162 | PF00018 | 0.621 | 
| LIG_SH3_3 | 207 | 213 | PF00018 | 0.656 | 
| LIG_SH3_3 | 247 | 253 | PF00018 | 0.469 | 
| LIG_TRAF2_1 | 240 | 243 | PF00917 | 0.495 | 
| LIG_TRAF2_1 | 254 | 257 | PF00917 | 0.492 | 
| LIG_WRC_WIRS_1 | 44 | 49 | PF05994 | 0.523 | 
| LIG_WW_1 | 162 | 165 | PF00397 | 0.522 | 
| MOD_CK1_1 | 274 | 280 | PF00069 | 0.677 | 
| MOD_CK1_1 | 88 | 94 | PF00069 | 0.486 | 
| MOD_CK2_1 | 150 | 156 | PF00069 | 0.390 | 
| MOD_CK2_1 | 251 | 257 | PF00069 | 0.625 | 
| MOD_Cter_Amidation | 328 | 331 | PF01082 | 0.783 | 
| MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.583 | 
| MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.616 | 
| MOD_GlcNHglycan | 206 | 209 | PF01048 | 0.801 | 
| MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.434 | 
| MOD_GSK3_1 | 112 | 119 | PF00069 | 0.520 | 
| MOD_GSK3_1 | 217 | 224 | PF00069 | 0.508 | 
| MOD_GSK3_1 | 274 | 281 | PF00069 | 0.620 | 
| MOD_GSK3_1 | 88 | 95 | PF00069 | 0.473 | 
| MOD_N-GLC_1 | 217 | 222 | PF02516 | 0.557 | 
| MOD_NEK2_1 | 26 | 31 | PF00069 | 0.622 | 
| MOD_NEK2_1 | 271 | 276 | PF00069 | 0.607 | 
| MOD_PIKK_1 | 185 | 191 | PF00454 | 0.671 | 
| MOD_PKA_2 | 221 | 227 | PF00069 | 0.500 | 
| MOD_Plk_1 | 217 | 223 | PF00069 | 0.535 | 
| MOD_Plk_1 | 92 | 98 | PF00069 | 0.523 | 
| MOD_Plk_4 | 116 | 122 | PF00069 | 0.571 | 
| MOD_Plk_4 | 141 | 147 | PF00069 | 0.438 | 
| MOD_Plk_4 | 92 | 98 | PF00069 | 0.446 | 
| MOD_ProDKin_1 | 209 | 215 | PF00069 | 0.618 | 
| MOD_SUMO_rev_2 | 230 | 238 | PF00179 | 0.584 | 
| MOD_SUMO_rev_2 | 242 | 247 | PF00179 | 0.389 | 
| MOD_SUMO_rev_2 | 293 | 300 | PF00179 | 0.544 | 
| MOD_SUMO_rev_2 | 52 | 60 | PF00179 | 0.566 | 
| TRG_ENDOCYTIC_2 | 165 | 168 | PF00928 | 0.550 | 
| TRG_ENDOCYTIC_2 | 249 | 252 | PF00928 | 0.474 | 
| TRG_ER_diArg_1 | 124 | 126 | PF00400 | 0.437 | 
| TRG_ER_diArg_1 | 192 | 195 | PF00400 | 0.649 | 
| TRG_ER_diArg_1 | 79 | 81 | PF00400 | 0.455 | 
| TRG_ER_diArg_1 | 8 | 10 | PF00400 | 0.611 | 
| TRG_ER_FFAT_2 | 108 | 119 | PF00635 | 0.554 | 
| TRG_NLS_MonoExtC_3 | 191 | 196 | PF00514 | 0.683 | 
| TRG_NLS_MonoExtN_4 | 190 | 196 | PF00514 | 0.677 | 
| TRG_Pf-PMV_PEXEL_1 | 58 | 62 | PF00026 | 0.374 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1PDU8 | Leptomonas seymouri | 84% | 98% | 
| A0A0S4JIJ0 | Bodo saltans | 60% | 97% | 
| A0A1X0NXX1 | Trypanosomatidae | 63% | 100% | 
| A0A3R7NHU1 | Trypanosoma rangeli | 63% | 99% | 
| A4HBQ1 | Leishmania braziliensis | 93% | 100% | 
| A4HZ53 | Leishmania infantum | 100% | 100% | 
| D0A1Q9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 62% | 100% | 
| E9AV21 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% | 
| P10881 | Bos taurus | 29% | 83% | 
| P32067 | Mus musculus | 27% | 81% | 
| P38656 | Rattus norvegicus | 27% | 81% | 
| P40796 | Drosophila melanogaster | 25% | 86% | 
| Q4QCG1 | Leishmania major | 97% | 100% | 
| V5DH11 | Trypanosoma cruzi | 60% | 100% |